Zein Pharma Pharmaceutical Industries had the honor of welcoming an official delegation from the European Union (EU in Syria) at the company’s headquarters. The high-level visit provided a valuable platform for constructive dialogue on the essential role played by national pharmaceutical manufacturing in supporting public health infrastructure, securing local medical supply chains, and meeting patient...
Under the sponsorship of Zein Pharma Pharmaceutical Industries, a scientific launch symposium was held in Hama Governorate to introduce Vonozein (Vonoprazan 10–20 mg). The symposium brought together a distinguished gathering of leading physicians, gastroenterologists, and healthcare professionals from across the governorate for an in-depth clinical dialogue on modern approaches to managing acid-related disorders and Gastroesophageal...
As part of its ongoing operational review and commitment to institutional excellence, Zein Pharma Pharmaceutical Industries convened its periodic meeting for members of its scientific offices. The session was dedicated to reviewing key achievements from the first quarter (Q1), evaluating market performance and sales indicators, and discussing strategic opportunities and operational challenges for the upcoming...
1. Introduction: Overcoming Challenges in LDL-C Target Achievement Despite the widespread use of statins, many high- and very-high-risk cardiovascular patients fail to reach their strict LDL-C goals due to treatment limits or statin intolerance. Managing dyslipidemia effectively often requires addressing both endogenous cholesterol production and intestinal absorption simultaneously. Bempo Plus, manufactured by Zein Pharma, combines...
1. Introduction: Addressing the Dual Challenge of Male LUTS/BPH Lower Urinary Tract Symptoms associated with Benign Prostatic Hyperplasia (LUTS/BPH) are broadly divided into two clinical components: Voiding Symptoms: Poor stream, hesitancy, straining, and terminal dribbling caused by bladder outlet obstruction. Storage (Irritative) Symptoms: Urgency, increased daytime frequency, urgency urinary incontinence (UUI), and nocturia. While α1-blocker monotherapy...
1. What is Tava liv? Tava liv is a prescription broad-spectrum antibiotic containing Levofloxacin, available in 500 mg and 750 mg strengths. It belongs to the fluoroquinolone class of antimicrobial agents and is engineered to target and eliminate bacterial pathogens causing moderate to severe respiratory tract infections. 2. Key Clinical Indications Tava liv is clinically...
1. What is Zivastine? Zivastine is a second-generation, long-acting histamine H1-receptor antagonist formulated with Ebastine. Developed to provide comprehensive control over allergic reactions, Zivastine targets both respiratory symptoms and dermatological allergy manifestations. Manufactured by Zein Pharma, Zivastine is delivered in modern Orodispersible Tablets (ODT) across flexible 10 mgand 20 mg dosage strengths. The fast-dissolving formulation...
1. What is Zaksan? Zaksan is an advanced prescription anticoagulant containing the active substance Apixaban. Available in 2.5 mg and 5 mg film-coated tablets (30-tablet packs), Zaksan belongs to the modern class of Direct Oral Anticoagulants (DOACs). It is clinically formulated to inhibit harmful blood clot formation in veins and arteries while supporting steady, unobstructed...
1. What is Zasek? Zasek is an advanced prescription gastrointestinal therapy containing Esomeprazole, the purified (S)-enantiomer of omeprazole. As a second-generation Proton Pump Inhibitor (PPI), Zasek delivers powerful, long-lasting reduction of gastric acid production. It is engineered to heal mucosal damage, relieve painful heartburn symptoms, and protect the upper gastrointestinal tract from acid-mediated injury. 2....
1. What is No Cholest? No Cholest is a targeted prescription lipid-lowering agent formulated with Ezetimibe (or as a synergistic combination therapy with statins/nutraceutical lipid complexes). Unlike traditional medications that focus solely on liver cholesterol synthesis, No Cholest acts selectively at the brush border of the small intestine to block dietary and biliary cholesterol absorption,...
Committed to advancing global healthcare through the development, manufacturing, and distribution of high-quality pharmaceutical formulations.
© 2026 Zein Pharma. All rights reserved.
